Drug intelligence / Profile preview

Tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

Development stage
Approved
Lead developer
Lantheus
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate is a coordination compound featuring a copper(I) center coordinated to four 2-methoxyisobutylisonitrile ligands. It is used as a component of the radiopharmaceutical agent Cardiolite, which is a technetium Tc99m-based imaging agent for assessing myocardial perfusion. The compound acts as a ligand precursor in the preparation of technetium Tc99m sestamibi, which accumulates in myocardial tissue and enables imaging of blood flow to detect coronary artery disease and localize myocardial ischemia[1][2][3][5].

Brand names
CardioliteCardio-Spect
Other names
tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroboratecopper tetramibi tetrafluoroboratelambda1-copper(1+) tetrakis(1-isocyano-2-methoxy-2-methylpropane) tetrafluoroboranuide

Beyond the preview

Go deeper on Tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call